|
|
||||||||
AJP - Lung Cellular and Molecular Physiology, Vol 262, Issue 4 446-L453, Copyright © 1992 by American Physiological Society
ARTICLES |
N. J. Gross and R. M. Schultz
Department of Medicine, Stritch School of Medicine, Loyola University of Chicago, Illinois.
Pulmonary alveolar surfactant is secreted by the alveolar epithelium in the form of lamellar bodylike structures that evolve sequentially into tubular myelin and vesicular forms that can be separated by centrifugation. Using an in vitro procedure by which the extracellular metabolism of pulmonary surfactant can be mimicked, namely cyclic variation in surface area, we previously reported that serine protease activity, which we called "convertase," was required for the conversion of tubular myelin to the vesicular form. In the present studies we explored the biochemical requirements of this activity and sought the enzyme in alveolar products. Convertase activity has unusual requirements; in addition to being dependent on repetitive variations in surface area (cycling), it requires the presence of a high g fraction of lung secretions that is heat stable and not inhibitable by diisopropyl fluorophosphate (DFP) or alpha 1-antitrypsin, both typical serine protease inhibitors. The enzyme does not require calcium ions and has a pH optimum of 7.4. Convertase appears to be a component of surfactant itself because the ability of purified surfactant to convert to the vesicular form on cycling is impaired by pretreating it with DFP. A protein of Mr 75,000 that reacts with DFP and is heat sensitive was found in alveolar lavage, lamellar body preparations, and lung homogenate. It copurifies with lung surfactant in sucrose gradients. A similar DFP-reactive protein was observed in stable human neoplastic peripheral airway cell lines that express type II properties, suggesting that it may be a product of type II cells. We tentatively conclude that surfactant convertase is a 75,000 serine protease that is closely associated with surfactant phospholipid and that may be a product of alveolar type II cells.
This article has been cited by other articles:
![]() |
T. Haller, P. Dietl, H. Stockner, M. Frick, N. Mair, I. Tinhofer, A. Ritsch, G. Enhorning, and G. Putz Tracing surfactant transformation from cellular release to insertion into an air-liquid interface Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L1009 - L1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ruppert, C. Pucker, P. Markart, R. Schmidt, F. Grimminger, W. Seeger, J. Sturzebecher, and A. Gunther Selective Inhibition of Large-to-Small Surfactant Aggregate Conversion by Serine Protease Inhibitors of the bis-Benzamidine Type Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 95 - 102. [Abstract] [Full Text] |
||||
![]() |
G. Maitra, K. Inchley, R. J. Novick, R. A. W. Veldhuizen, J. F. Lewis, and F. Possmayer Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L67 - L74. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Malloy, R. A. W. Veldhuizen, and J. F. Lewis Effects of ventilation on the surfactant system in sepsis-induced lung injury J Appl Physiol, February 1, 2000; 88(2): 401 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dhand, J. Young, A. Teng, S. Krishnasamy, and N. J. Gross Is dipalmitoylphosphatidylcholine a substrate for convertase? Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L19 - L24. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. BELAI, J. M. HERNÁNDEZ-JUVIEL, R. BRUNI, A. J. WARING, and F. J. WALTHER Addition of alpha 1-Antitrypsin to Surfactant Improves Oxygenation in Surfactant-deficient Rats Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 917 - 923. [Abstract] [Full Text] |
||||
![]() |
H. Clark, L. Allen, E. Collins, F. Barr, L. Dobbs, G. Putz, J. Goerke, and S. Hawgood Localization of a candidate surfactant convertase to type II cells, macrophages, and surfactant subfractions Am J Physiol Lung Cell Mol Physiol, March 1, 1999; 276(3): L452 - L458. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oulton, E. Edwards, and K. Handa Convertase activity in alveolar surfactant and lamellar bodies in fetal, newborn, and adult rabbits J Appl Physiol, January 1, 1999; 86(1): 71 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. GÜNTHER, R. SCHMIDT, A. FEUSTEL, U. MEIER, C. PUCKER, M. ERMERT, and W. SEEGER Surfactant Subtype Conversion Is Related to Loss of Surfactant Apoprotein B and Surface Activity in Large Surfactant Aggregates . Experimental and Clinical Studies Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 244 - 251. [Abstract] [Full Text] |
||||
![]() |
F. Barr, H. Clark, and S. Hawgood Identification of a putative surfactant convertase in rat lung as a secreted serine carboxylesterase Am J Physiol Lung Cell Mol Physiol, March 1, 1998; 274(3): L404 - L410. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Gross, R. Veldhuizen, F. Possmayer, and R. Dhand Surfactant convertase action is not essential for surfactant film formation Am J Physiol Lung Cell Mol Physiol, November 1, 1997; 273(5): L907 - L912. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |